ARS Pharmaceuticals, Inc.

NasdaqGM:SPRY 주식 보고서

시가총액: US$1.3b

ARS Pharmaceuticals 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Rich Lowenthal

최고 경영자

US$10.0m

총 보상

CEO 급여 비율6.2%
CEO 임기2yrs
CEO 소유권5.8%
경영진 평균 재임 기간2.6yrs
이사회 평균 재임 기간3.3yrs

최근 관리 업데이트

Recent updates

ARS Pharmaceuticals: Demand Curve Is Key Unknown

Nov 20

We're Interested To See How ARS Pharmaceuticals (NASDAQ:SPRY) Uses Its Cash Hoard To Grow

Sep 13
We're Interested To See How ARS Pharmaceuticals (NASDAQ:SPRY) Uses Its Cash Hoard To Grow

ARS Pharmaceuticals: A Decent Bet For Upside After Neffy Approval

Sep 06

ARS Pharmaceuticals On Track With Neffy Despite Regulatory Hurdles

Jun 25

We're Not Very Worried About ARS Pharmaceuticals' (NASDAQ:SPRY) Cash Burn Rate

Mar 18
We're Not Very Worried About ARS Pharmaceuticals' (NASDAQ:SPRY) Cash Burn Rate

ARS Pharmaceuticals (NASDAQ:SPRY) Is In A Good Position To Deliver On Growth Plans

Nov 14
ARS Pharmaceuticals (NASDAQ:SPRY) Is In A Good Position To Deliver On Growth Plans

Here's Why We're Not Too Worried About ARS Pharmaceuticals' (NASDAQ:SPRY) Cash Burn Situation

May 12
Here's Why We're Not Too Worried About ARS Pharmaceuticals' (NASDAQ:SPRY) Cash Burn Situation

CEO 보상 분석

Rich Lowenthal 의 보수는 ARS Pharmaceuticals 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$49m

Jun 30 2024n/an/a

-US$45m

Mar 31 2024n/an/a

-US$50m

Dec 31 2023US$10mUS$620k

-US$54m

Sep 30 2023n/an/a

-US$62m

Jun 30 2023n/an/a

-US$53m

Mar 31 2023n/an/a

-US$42m

Dec 31 2022US$909kUS$75k

-US$35m

보상 대 시장: Rich 의 총 보상 ($USD 10.04M )은 US 시장( $USD 5.37M ).

보상과 수익: 회사가 수익성이 없는 동안 Rich 의 보상이 증가했습니다.

CEO

Rich Lowenthal (58 yo)

2yrs

테뉴어

US$10,039,096

보상

Mr. Richard E. Lowenthal, also known as Rich, MS, MSEL, MBA, He serves as Director, Chief Executive Officer & President at ARS Pharmaceuticals, Inc. since November 08, 2022. He served as Head of Regulatory...

리더십 팀

이름위치테뉴어보상소유권
Richard Lowenthal
Founder2yrsUS$10.04m5.77%
$ 76.0m
Sarina Tanimoto
Co-Founder & Chief Medical Officerno dataUS$4.79m3.51%
$ 46.2m
Alexander Fitzpatrick
Chief Legal Officer & Secretary1.8yrsUS$5.32m0.092%
$ 1.2m
Robert Bell
Co-Founder & Chief Science Officerno data데이터 없음4.34%
$ 57.1m
Kathleen Scott
Chief Financial Officer2.6yrs데이터 없음0.014%
$ 178.8k
Brian Dorsey
Chief Operations Officerno data데이터 없음0.0062%
$ 81.6k
Daniel Relovsky
Senior Vice President of Marketing2.8yrs데이터 없음데이터 없음
Harris Kaplan
Executive Vice President of Commercial Strategy2.8yrs데이터 없음데이터 없음
Eric Karas
Chief Commercial Officer2.6yrsUS$618.61k0.0059%
$ 77.2k
Justin Chakma
Chief Business Officer & Secretary2yrs데이터 없음데이터 없음

2.6yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 관리: SPRY 의 관리팀은 경험 ( 2.6 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Richard Lowenthal
Founder2yrsUS$10.04m5.77%
$ 76.0m
Phillip Schneider
Independent Directorno dataUS$261.30k0%
$ 0
Pratik Shah
Chairman of the Boardno dataUS$508.80k4.96%
$ 65.4m
Brenton L. Saunders
Director3.5yrsUS$238.80k0%
$ 0
Rajeev Dadoo
Independent Director3.3yrsUS$256.30k데이터 없음
Peter Kolchinsky
Independent Director3.3yrsUS$253.80k데이터 없음
Saqib Islam
Independent Director2yrsUS$250.05k0.016%
$ 206.5k
Thomas Casale
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Michael Kaliner
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Motohiro Ebisawa
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Michael Kelly
Independent Directorno dataUS$248.80k0.086%
$ 1.1m
Richard Lockey
Member of Scientific Advisory Boardno data데이터 없음데이터 없음

3.3yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 이사회: SPRY 의 이사회는 경험(평균 재직 기간 3.3 년)으로 간주됩니다.